From Raynaud's Phenomenon to Systemic Sclerosis (Scleroderma): Lack or Exhaustion of Adaptation?

Advances in Organ Biology

Volumn 6, Issue C, 1998, Pages 241-253

  Cerinic, Marco Matucci ^a   Generini, Sergio ^a   Pignone, Alberto ^a   Cagnoni, Mario ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001203162     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60018-X     Document Type: Article

References (50)

1. Alexander E.L., Firestein G.S., and Leitl G. Scleroderma heart disease: evidence for cold-induced abnormalities of myocardial function and perfusion. Arthritis Rheum. 24 suppl. (1981) 58 [Abstr.].
2. Belch J.J.F., McLaren M., Anderson J., Lowe G.D., Sturrock R.D., Capell H.A., Forbes C.D., Mikhailidi S.D.P., Jeremy J.Y., and Dandona P. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot. Essent. Fatty Acids 17 (1985) 1-9
3. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Ai K.J., Bamshad B., Esterson M., and Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85 (1990) 1260-1266
4. Blann A.D., Illingworth K., and Jayson M.I.V. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J. Rheumatol. 20 (1993) 1325-1330
5. Bruckdorfer K.R., Hillary J.B., Bunce T., Vancheeswaran R., and Black C.M. Increased susceptibility to oxidation of low density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 38 (1995) 1060-1067
6. Cannon P.J., Hassar M., Case D.B., Casarella W.J., Sommers S.C., and LeRoy E.C. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine 53 (1974) 1-46
7. Carvalho D., Savage C.O.S., Black C.M., and Pearson J.D. IgG antiendothelial cell autoantibodies from scleroderma patients induce leucocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium derived cytokines. J. Clin. Invest. 97 (1996) 111-119
8. Casciola-Rosen L., Wigley F., and Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis. J. Exp. Med. 185 (1997) 71-79
9. Coffman J. The diagnosis of Raynaud's phenomenon. Clin. Rheumatol. 12 (1994) 283-290
10. Curmulte J., Badwes J.A., Robinson J.M., Karnovsy M.J., and Karnovsky M.L. Studies on the mechanism of superoxide release from human neutrophils stimulated with arachidonate. J. Biol. Chem. 259 (1984) 11851-11857
11. Das D.K., Maulik K.N., and Moraru I.I. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hypertermia and oxidative stress. J. Mol. Cell. Cardiol. 27 (1995) 181-185
12. DeFily D., and Chilian W.M. Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am. J. Physiol. 34 (1993) H700-H706
13. Duncan R.F., and Hershey J.W.B. Protein synthesis and protein phosphorilation during heat stress recovery and adaptation. J. Cell. Biol. 109 (1989) 1467-1481
14. Emerit I. Chromosomal breakage in systemic sclerosis and related disorders. Dermatologica 153 (1976) 145-146
15. Fahey P.J., Utell M.J., Condemi J.J., Green R., and Hyde R.W. Raynaud's phenomenon of the lung. Am. J. Med. 76 (1984) 263-269
16. Fischer A.B., Dodia C., Ayene I., and Al-Mehdi A. Ischemia reperfusion injury to the lung. Ann. N.Y. Acad. Sci. 273 (1994) 197-207
17. Gearing A.J.H., and Newman W. Circulating adhesion molecules in disease. Immunol. Today 14 (1993) 506-512
18. Hammond S.L., Loi Y.K., and Markert C.L. Diverse forms of stress lead to new patterns of gene expression through a common and essential metabolic pathway. Proc. Nat. Acad. Sci. 79 (1982) 3485-3488
19. Herrick A.L., Rieley F., Schofield D., Hollis S., Braganza J.M., and Jayson M.I.V. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J. Rheumatol. 21 (1994) 1477-1483
20. Horrobin D.F. Essential fatty acid and prostaglandin metabolism in Sjoegren syndrome, systemic sclerosis and rheumatoid arthritis. Scand. J. Rheumatol. 61 suppl. (1986) 242-245
21. Housset E., Emerit I., and Baulon A. Anomalies chromosomiques dans la sclerodermie generalisée: études de 10 malades. C. R. Acad. Sci. (Paris) 269 (1969) 413-420
22. Jornot L., Mirault M.E., and Junod A.F. Differential expression of Hsp 70 stress proteins in human endothelid cells exposed to heat shock and hydrogen peroxide. Am. J. Resp. Cell. Mol. Biol. 5 (1991) 265-275
23. Kahaleh B.M. Endothelin an endothelid dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthritis Rheum. 34 (1991) 978-983
24. Kahaleh, B.M., Fan, P.S., Matucci Cerinic, M., and Ignarro, L. (submitted for publiclation). Nitric oxide in scleroderma: reduced production and blunted response to cold.
25. Kahaleh B.M., and Matucci Cerinic M. Raynaud's phenomenon and scleroderma: dysregulated neuroendothelial control of vascular tone. Arthritis Rheum. 38 (1995) 1-4
26. Kubes P., Suzuli M., and Granger D.N. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc. Nat. Acad. Sci. 88 (1991) 4651-4655
27. Kurose I., and Granger D.N. Evidence implicating xanthine oxidase and neutrophils in reperfusion induced microvascular dysfunction. Ann. N.Y. Acad. Sci. 723 (1995) 158-179
28. Kurose I., Wolf R., and Granger D.N. Modulation of ischemia reperfusion induced microvascular dysfunction by nitric oxide. Circ. Res. 74 (1994) 376-382
29. Lau C.S., Bridges A.B., Muir A., Scott N., Bancroft A., and Belch J.J.F. Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon. Br. J. Rheumatol. 31 (1992) 375-380
30. Lau C.S., O'Dowd A., and Belch J.J.F. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann. Rheum. Dis. 51 (1992) 249-259
31. Lu D., Maulik N., Moraru I., Kreutzer D.L., and Das D.K. Molecular adaptation of vascular endothelial cells to oxidative stress. Am. J. Physiol. 264 (1993) C715-C721
32. Matucci Cerinic M., Kahaleh B.M., and Leroy E.C. Vascular involvement: pathogenesis. In: Furst D., and Clements P. (Eds). Systemic Sclerosis (1995), Lea & Febiger, New York 153
33. Matucci Cerinic M., Pietrini U., and Marabini S. Local venomotor response to intravenous infusion of substance P and glyceryl trinitrate in systemic sclerosis. Clin. Exp. Rheumatol. 8 (1990) 561-565
34. Maulik N., Liu X., Subramanian R., and Das D.K. Release of endothelin during reperfusion of ischemic myocardium. Endothelin 1 release from reperfused heart. Am. J. Cardiovasc. Pathol. 4 (1992) 133-144
35. Miyazaki T., and Zipes D.P. Protection against autonomic denervation following acute myocardial infarction by preconditioning ischemia. Circ. Res. 64 (1989) 437-448
36. Murrel D.F. A radical proposal for the pathogenesis of scleroderma. J. Am. Acad. Dermatol. 28 (1993) 78-85
37. Murrel G.A.C., Francis M.J.O., and Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265 (1990) 659-665
38. Murry C.E., Richard V.J., Reimer K.A., and Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66 (1990) 913-931
39. Otani H., Prasad M.R., Jones R.M., and Das D.K. Mechanisms of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am. J. Physiol. 257 (1989) H252-H258
40. Paller M.S., and Greene E.L. Role of calcium in reprfusion injury of the kidney. Ann. N.Y. Acad. Sci. 273 (1994) 59-70
41. Pruzanski W., Lee P., Stefanski E., Sternby B., and Vadas P. Hyphospholipasemia A2 in systemic sclerosis. J. Rheumatol. 17 (1990) 1182-1186
42. Reilly I.A.G., Roy L., and Fitzgerald G.A. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br. Med. J. 292 (1986) 1037-1039
43. Salmenson B.D., Reisman J., Sinclar S.H., and Burge D. Macular capillary hemodynamic changes associated with Raynaud's phenomenon. Ophthalmology 99 (1992) 914-919
44. Schott R.J., Rohmann S., Braun E.R., and Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 66 (1990) 1133-1142
45. Simonini G., Matucci Cerinic M., Generini S., Zoppi M., Anichini M., Cesaretti A., Pignone A., Falcini F., Lotti T., and Cagnoni M. Oxidative stress in systemic sclerosis. Mol. Cell. Biochem. (1998) (In press.)
46. Spisani S., Dovigo L., and Colamussi V. Leukocyte migration and phagocytosis in progressive systemic sclerosis. Scand. J. Rheumatol. 81 (1981) 299-300
47. Stein C.M., Tanner S.B., Awad J.A., Roberts L.J.I., and Morrow J.D. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 39 (1996) 1146-1150
48. Ter Borg E.J., Piersma-Wichers G., Smit A.J., Kallemberg C.G.M., and Wounda A.A. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Semin. Arthritis Rheum. 24 (1994) 40-47
49. Vancheeswaran R., Magoulas T., Efrat G., Penny R.M., and Black C.M. Circulating endothelin 1 levels in systemic sclerosis subsets: A marker of fibrosis or vascular dysfunction?. J. Rheumatol. 21 (1994) 1838-1844
50. Win K.D.A., Haubauer I., Krishna M.C., DeGraff W., Ganson J., and Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Nat. Acad. Sci. 90 (1993) 13-17